NCT04597749已完成不适用
Nebula Study: Comparison of Sleep Screener Apps and Home Sleep Apnea Tests to Polysomnography
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ResMed
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- AHI value. Clinical decision for treatment output (Y to CPAP or N to CPAP) of Screener apps and HSAT compared to PSG.
研究概览
简要总结
This is a prospective, unblinded, open-label, single group study. All subjects will undergo concurrent screener app, HSAT testing, and in-lab polysomnography.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participant is 18 years of age or older
- •Participant is willing to provide informed consent
- •Participant is willing to participate in all study related procedures
排除标准
- •Unable to cease PAP therapy during PSG (if currently using)
- •Requires use of oxygen therapy during sleep
- •Diagnosis of untreated clinically relevant sleep disorder (other than SDB)
- •Participant is unsuitable to participate in the study in the opinion of the investigator
- •Participant has a permanent pacemaker, sustained non-sinus cardiac arrhythmias, and/or takes alpha blocker or short acting nitrate medication.
结局指标
主要结局
AHI value. Clinical decision for treatment output (Y to CPAP or N to CPAP) of Screener apps and HSAT compared to PSG.
时间窗: Day 1
The PSG clinical decision for treatment is defined as AHI≥15. Screener apps and HSATs provide AHI values that will be used for comparison.
次要结局
- OSA severity categories (normal, mild, moderate, severe) of Screnner apps and HSAT compared to PSG.(Day 1)
研究者
研究点 (2)
Loading locations...
相似试验
尚未招募
3 期
ESPRIT TOXIL-2 UNSW PSO 6361rlL-2 toxicityInterleukin-2 therapyHIVInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12605000407695niversity of New South Wales, Sydney, Australia.168
已完成
不适用
Itraconazole Versus Amphotericin B for the treatment of Penicilliosis (IVAP)Penicillium marneffeiInfections and InfestationsHuman immunodeficiency virus (HIV) disease resulting in infectious and parasitic diseasesISRCTN97524945niversity of Oxford (UK)440
进行中（未招募）
不适用
An open-label, randomised pilot study comparing the efficacy, safety and tolerability of raltegravir with protease inhibitor-based therapy in treatment-naïve, HIV/Hepatitis C co-infected injecting drug users receiving methadoneHIV-1/Hepatitis C co-infected patientsMedDRA version: 14.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-018326-39-IEDepartment of Genito-Urinary Medicine and Infectious Diseases
尚未招募
Unknown
Study Comparing Two Heart Monitoring DevicesCTRI/2024/04/065617itto Denko Asia Technical Centre Pte Ltd,
Unknown
不适用
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic MalignanciesHematologic MalignanciesNCT02386332Instituto de Investigacion Sanitaria La Fe206